| Transaction Date | Filer | Title | Filing | Transaction Type | Shares Traded | Price | Total Held* |
|---|---|---|---|---|---|---|---|
| Oct 07, 2024 | Director | Form 4 | Open market or private sale of non-derivative or derivative security | 19 | $536.18 | 4,222 | |
| Oct 07, 2024 | Director | Form 4 | Open market or private sale of non-derivative or derivative security | 1 | $537.15 | 4,221 | |
| Oct 02, 2024 | CVP & Chief Financial Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | 74 | |
| Oct 02, 2024 | CVP & Chief Financial Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | 2,066 | |
| Oct 02, 2024 | CVP & Chief Financial Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | 2,031 | -- | -- | |
| Oct 02, 2024 | CVP & Chief Financial Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | 4,523 | -- | -- | |
| Sep 30, 2024 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 88 | $528.07 | 9,916 | |
| Sep 30, 2024 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 69 | $528.07 | 1,488 | |
| Sep 30, 2024 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 41 | $528.07 | 1,878 | |
| Sep 05, 2024 | Director | Form 4 | Open market or private sale of non-derivative or derivative security | 1 | $516.93 | 4,271 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.